Scholarly Index
Joseph R. Arron
Atara Biotherapeutics (United States); 17,787 total citations; 170 total publications; best world rank #312
Atara Biotherapeutics (United States)
17,787Total citations
170Total publications
58H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| IL-33, ST2, and ILC Pathways | Lifetime | 312 | US 140 | 96.98 |
| NF-κB Signaling Pathways | Lifetime | 890 | US 352 | 93.17 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 419 | US 115 | 93.08 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 452 | US 92 | 88.76 |